全文获取类型
| 收费全文 | 47828篇 |
| 免费 | 3748篇 |
| 国内免费 | 88篇 |
专业分类
| 耳鼻咽喉 | 709篇 |
| 儿科学 | 1155篇 |
| 妇产科学 | 1230篇 |
| 基础医学 | 6227篇 |
| 口腔科学 | 995篇 |
| 临床医学 | 5757篇 |
| 内科学 | 8790篇 |
| 皮肤病学 | 532篇 |
| 神经病学 | 3822篇 |
| 特种医学 | 1718篇 |
| 外科学 | 7831篇 |
| 综合类 | 711篇 |
| 一般理论 | 63篇 |
| 预防医学 | 4603篇 |
| 眼科学 | 1018篇 |
| 药学 | 3252篇 |
| 中国医学 | 66篇 |
| 肿瘤学 | 3185篇 |
出版年
| 2023年 | 348篇 |
| 2022年 | 591篇 |
| 2021年 | 1352篇 |
| 2020年 | 720篇 |
| 2019年 | 1217篇 |
| 2018年 | 1338篇 |
| 2017年 | 971篇 |
| 2016年 | 1011篇 |
| 2015年 | 1171篇 |
| 2014年 | 1695篇 |
| 2013年 | 2094篇 |
| 2012年 | 3309篇 |
| 2011年 | 3326篇 |
| 2010年 | 1756篇 |
| 2009年 | 1590篇 |
| 2008年 | 2619篇 |
| 2007年 | 2682篇 |
| 2006年 | 2388篇 |
| 2005年 | 2281篇 |
| 2004年 | 2112篇 |
| 2003年 | 1896篇 |
| 2002年 | 1681篇 |
| 2001年 | 982篇 |
| 2000年 | 943篇 |
| 1999年 | 785篇 |
| 1998年 | 459篇 |
| 1997年 | 404篇 |
| 1996年 | 357篇 |
| 1995年 | 331篇 |
| 1994年 | 242篇 |
| 1993年 | 208篇 |
| 1992年 | 619篇 |
| 1991年 | 535篇 |
| 1990年 | 515篇 |
| 1989年 | 506篇 |
| 1988年 | 492篇 |
| 1987年 | 435篇 |
| 1986年 | 476篇 |
| 1985年 | 468篇 |
| 1984年 | 371篇 |
| 1983年 | 312篇 |
| 1982年 | 214篇 |
| 1980年 | 220篇 |
| 1979年 | 355篇 |
| 1978年 | 241篇 |
| 1977年 | 224篇 |
| 1974年 | 229篇 |
| 1973年 | 205篇 |
| 1972年 | 200篇 |
| 1969年 | 200篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
11.
12.
13.
14.
Yinong Young-Xu Julia Thornton Snider Robertus van Aalst Salaheddin M. Mahmud Edward W. Thommes Jason K.H. Lee David P. Greenberg Ayman Chit 《Vaccine》2019,37(11):1484-1490
Background
Observational studies of the relative effectiveness of influenza vaccines are essential for public health decision making. Their estimates, however, are subject to bias due to unmeasured confounders. Instrumental variable (IV) methods can control for observed and unobserved confounders.Methods
We used linked electronic medical record databases in the Veterans Health Administration (VHA) as well as Medicare administrative files to examine the relative vaccine effectiveness (rVE) of high-dose influenza vaccine (HD) versus standard-dose influenza vaccines (SD) in preventing hospitalizations among VHA-enrolled Veterans ≥65?years of age during 5 influenza seasons (2010–2011 through 2014–2015). Using multivariable IV Poisson regression modeling to address unmeasured confounding and bias, we analyzed the data by each season and through longitudinal analysis of all five seasons.Findings
We included 3,638,924 person–influenza seasons of observation where 158,636 (4%) were among HD vaccine recipients and 3,480,288 (96%) were among SD vaccine recipients. Of the 1,728,562 Veterans, 1,702,824 (98.5%) were male and 1,299,412 (75%) were non-Hispanic white. Based on the longitudinal analysis of all five seasons, the IV-adjusted rVE estimate of HD vs. SD was 10% (95% CI, 8–12%) against all-cause hospitalization; 18% (95% CI, 15–21%) against cardiorespiratory-associated hospitalization; and 14% (95% CI, 6–22%) against influenza/pneumonia-associated hospitalization. The findings by season were similar.Interpretation
Our analysis of VHA clinical data collected from approximately 1.7 million Veterans 65?years and older during five seasons demonstrates that high-dose influenza vaccine is more effective than standard-dose influenza vaccines in preventing influenza- or pneumonia-associated hospitalizations, cardiorespiratory hospitalizations, and all-cause hospitalizations. 相似文献15.
16.
J.A. Hannam S.J. Mitchell D. Cumin C. Frampton A.F. Merry M.R. Moore C.J. Kruger 《British journal of anaesthesia》2019,122(2):198-205
Background
Etomidate is frequently selected over propofol for induction of anaesthesia because of a putatively favourable haemodynamic profile, but data confirming this perception are limited.Methods
Patients undergoing cardiac surgery were randomised to induction of anaesthesia with propofol or etomidate. Phase I (n=75) was conducted as open-label, whereas Phase II (n=75) was double blind. Mean arterial blood pressure (MAP) and boluses of vasopressor administered after induction were recorded. The primary endpoint was the area under the curve below baseline MAP (MAP-time integral) during the 10 min after induction. Secondary endpoints were the use of vasopressors over the same period, and the effect of blinding on the aforementioned endpoints. Groups were compared using regression models with phase and anaesthetist as factors.Results
The mean difference between etomidate and propofol in the MAP-time integral below baseline was 2244 mm Hg s (95% confidence interval, 581–3906; P=0.009), representing a 34% greater reduction with propofol. Overall, vasopressors were used in 10/75 patients in the etomidate group vs 21/75 in the propofol group (P=0.38), and in 20/74 patients during the blinded phase vs 11/76 during the open-label phase (P=0.31). The interaction between randomisation and phase (open-labelled or blinded) was not significant for either primary (P=0.73) or secondary endpoints (P=0.90).Conclusions
Propofol caused a 34% greater reduction in MAP-time integral from baseline after induction of anaesthesia than etomidate, despite more frequent use of vasopressors with propofol, confirming the superior haemodynamic profile of etomidate in this context. The proportion of patients receiving vasopressors increased slightly, albeit not significantly, in both groups in the blinded phase.Clinical trial registration
Australian and New Zealand Clinical Trials Registry, ACTRN12614000717651. 相似文献17.
18.
This paper reviews the published literature on a group of developmental disorders of the retina and retinal pigment epithelium which result in focal abnormalities in one or both eyes. They are often asymptomatic, found on routine examination and are generally non-progressive. Some are associated with other systemic abnormalities.Subject terms: Retinal diseases, Eye abnormalities 相似文献
19.
20.
Andriy
Derkach Steven C. Moore Simina M. Boca Joshua N. Sampson 《Statistics in medicine》2020,39(18):2423-2436
We consider the scenario where there is an exposure, multiple biologically defined sets of biomarkers, and an outcome. We propose a new two-step procedure that tests if any of the sets of biomarkers mediate the exposure/outcome relationship, while maintaining a prespecified familywise error rate. The first step of the proposed procedure is a screening step that removes all groups that are unlikely to be strongly associated with both the exposure and the outcome. The second step adapts recent advances in postselection inference to test if there are true mediators in each of the remaining candidate sets. We use simulation to show that this simple two-step procedure has higher statistical power to detect true mediating sets when compared with existing procedures. We then use our two-step procedure to identify a set of Lysine-related metabolites that potentially mediate the known relationship between increased body mass index and the increased risk of estrogen-receptor positive breast cancer in postmenopausal women. 相似文献